Cannapharmarx CPMD
OTC CPMD
$0.00 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Cannapharmarx, Inc. (CPMD) EBITDA Margin (2024 - 2026)

Updated

Cannapharmarx's EBITDA Margin came in at -130.46% for Q2 2026, up 232.64 percentage points from -363.10% a year earlier but down 24.23 percentage points from the prior quarter.

Analysis

Cannapharmarx, Inc. (CPMD) EBITDA Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cannapharmarx reported EBITDA Margin of -165.02%, up 101.74 percentage points year-over-year; for FY2024, it came in at -442.72%.

  • The five-year range for quarterly EBITDA Margin is -2968.98% (Q1 2024) to -106.23% (Q1 2026).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -130.46%
Mar 31, 2026 -106.23%
Sep 30, 2025 -142.50%
Jun 30, 2025 -363.10%
Mar 31, 2025 -196.55%
Dec 31, 2024 -335.00%
Sep 30, 2024 -165.29%
Mar 31, 2024 -2,968.98%
API Access

Cannapharmarx, Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CPMD&period=max&api_key=YOUR_API_KEY